|
|
Volumn 97, Issue 14, 2005, Pages 1028-1029
|
|
New studies look beyond EGFR mutations for clues to sensitivity to erlotinib
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLIN DEPENDENT KINASE 2;
DOCETAXEL;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
GEFITINIB;
PLACEBO;
PROTEIN KINASE B;
UVOMORULIN;
VIMENTIN;
CELL CYCLE PROTEIN;
CYCLIN DEPENDENT KINASE INHIBITOR 1A;
ONCOPROTEIN;
PROTEIN KINASE INHIBITOR;
PROTEIN SERINE THREONINE KINASE;
QUINAZOLINE DERIVATIVE;
ANTINEOPLASTIC ACTIVITY;
CANCER INHIBITION;
CANCER RESISTANCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG RESPONSE;
DRUG SENSITIVITY;
ENZYME ACTIVITY;
ENZYME PHOSPHORYLATION;
EXON;
GENE AMPLIFICATION;
GENE MUTATION;
GLIOBLASTOMA;
HUMAN;
LUNG NON SMALL CELL CANCER;
MUTATIONAL ANALYSIS;
NOTE;
PHARMACOGENETICS;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN EXPRESSION;
ANIMAL;
ARTICLE;
CANADA;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG RESISTANCE;
GENETICS;
METABOLISM;
MULTICENTER STUDY;
MUTATION;
PHOSPHORYLATION;
RETROSPECTIVE STUDY;
ANIMALS;
CANADA;
CELL CYCLE PROTEINS;
CLINICAL TRIALS;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
DRUG RESISTANCE, NEOPLASM;
MULTICENTER STUDIES;
MUTATION;
PHOSPHORYLATION;
PROTEIN KINASE INHIBITORS;
PROTEIN-SERINE-THREONINE KINASES;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-AKT;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RETROSPECTIVE STUDIES;
|
|
EID: 23244460078
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/dji225 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|